SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-21-006841
Filing Date
2021-06-17
Accepted
2021-06-17 19:42:05
Documents
2
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1718
2 POWER-OF-ATTORNEY poageld.txt EX-24.TXT 3711
  Complete submission text file 0001179110-21-006841.txt   6963
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O A.P. PHARMA, INC. 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
Gelder Mark S. MD (Reporting) CIK: 0001564390 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 211026596